Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

News Conference News ACC 2025

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

Michael O'Riordan

April 04, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Conference News ACC 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Yael L. Maxwell

March 30, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Conference News ACC 2025

WARRIOR: No Clear Answers on How to Best Treat INOCA

Yael L. Maxwell

March 29, 2025

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

Presentation ACC 2024

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Presenter: Martin S. Maron

April 08, 2024

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

L.A. McKeown

April 07, 2024

News Conference News ACC 2024

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

Caitlin E. Cox

April 06, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Conference News ACC 2023

PULSED AF ‘Strengthens the Case’ for Pulsed-Field Ablation in AF

Todd Neale

March 06, 2023

News Conference News ACC 2023

COAPT at 5 Years: MitraClip Still Ahead, but Deaths and Crossovers Cast Shadows

Shelley Wood

March 05, 2023

News Conference News ACC 2023

TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR

Todd Neale

March 04, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Shelley Wood

April 03, 2022

Advertisement

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

WARRIOR: No Clear Answers on How to Best Treat INOCA

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

What’s Going to Be Hot at ACC 2024

PULSED AF ‘Strengthens the Case’ for Pulsed-Field Ablation in AF

COAPT at 5 Years: MitraClip Still Ahead, but Deaths and Crossovers Cast Shadows

TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR

What’s Going to Be Hot at ACC/WCC 2023?

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content